Predicting Severity of Radiation Induced Lymphopenia in Individual Proton Therapy Patients for Varying Dose Rate and Fractionation Using Dynamic 4-Dimensional Blood Flow Simulations

被引:13
|
作者
Mccullum, Lucas [1 ,2 ]
Shin, Jungwook [3 ]
Xing, Stella [1 ,2 ]
Beekman, Chris [1 ,2 ]
Schuemann, Jan [1 ,2 ]
Hong, Theodore [1 ,2 ]
Duda, Dan [1 ,2 ]
Mohan, Radhe [4 ]
Lin, Steven H. [4 ]
Correa-Alfonso, Camilo M. [5 ]
Domal, Sean [5 ]
Withrow, Julia [5 ]
Bolch, Wesley [5 ]
Paganetti, Harald [1 ,2 ]
Grassberger, Clemens [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] NCI, Radiat Epidemiol Branch, Rockville, MD USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX USA
[5] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL USA
基金
美国国家卫生研究院;
关键词
HEPATOCELLULAR-CARCINOMA; HYPER-RADIOSENSITIVITY; LYMPHOCYTE RECOVERY; PERIPHERAL-BLOOD; BONE-MARROW; CANCER; FIBROBLASTS; RADIOTHERAPY; PROGNOSIS; APOPTOSIS;
D O I
10.1016/j.ijrobp.2023.01.054
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Radiation-induced lymphopenia has gained attention recently as the result of its correlation with survival in a range of indications, particularly when combining radiation therapy (RT) with immunotherapy. The purpose of this study is to use a dynamic blood circulation model combined with observed lymphocyte depletion in patients to derive the in vivo radiosensitiv-ity of circulating lymphocytes and study the effect of RT delivery parameters.Methods and Materials: We assembled a cohort of 17 patients with hepatocellular carcinoma treated with proton RT alone in 15 fractions (fx) using conventional dose rates (beam-on time [BOT], 120 seconds) for whom weekly absolute lymphocyte counts (ALCs) during RT and follow-up were available. We used HEDOS, a time-dependent, whole-body, blood flow computational frame-work, in combination with explicit liver blood flow modeling, to calculate the dose volume histograms for circulating lymphocytes for changing BOTs (1 second-300 seconds) and fractionations (5 fx, 15 fx). From this, we used the linear cell survival model and an exponential model to determine patient-specific lymphocyte radiation sensitivity, a, and recovery, s, respectively.Results: The in vivo-derived patient-specific a had a median of 0.65 Gy ⠂1 (range, 0.30-1.38). Decreasing BOT to 1 second led to an increased average end-of-treatment ALC of 27.5%, increasing to 60.3% when combined with the 5-fx regimen. Decreasing to 5 fx at the conventional dose rate led to an increase of 17.0% on average. The benefit of both increasing dose rate and reducing the number of fractions was patient specific ࣧpatients with highly sensitive lymphocytes benefited most from decreasing BOT, whereas patients with slow lymphocyte recovery benefited most from the shorter fractionation regimen.Conclusions: We observed that increasing dose rate at the same fractionation reduced ALC depletion more significantly than reducing the number of fractions. High-dose-rates led to an increased sparing of lymphocytes when shortening the fraction-ation regimen, particularly for patients with radiosensitive lymphocytes at elevated risk.& COPY; 2023 Elsevier Inc. All rights reserved.
引用
收藏
页码:1226 / 1233
页数:8
相关论文
共 1 条
  • [1] High Dose Rate and Fractionation to Reduce Radiation-Induced Lymphopenia: In Vivo Derivation of Lymphocyte Radiosensitivity Using Patient-Specific Blood Flow Simulations
    McCullum, L.
    Xing, S. S.
    Shin, J.
    McNamara, A. L.
    Alfonso, C.
    Domal, S.
    Withrow, J.
    Bolch, W.
    Hong, T. S.
    Lin, S. H.
    Mohan, R.
    Paganetti, H.
    Grassberger, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E503 - E504